Could a Two-Drug punch finally knock out whipworm in kids?
NCT ID NCT06188715
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether combining two drugs—moxidectin and albendazole—works better than albendazole alone for treating whipworm infections in children aged 6 to 12. The trial took place in Tanzania and involved 224 children. Researchers measured how many children were cured and how much the worm egg count dropped after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- moxidectin and albendazole combination
- What this could lead to
- If it works, this could provide a more effective treatment for whipworm infections in children, reducing the need for repeat dosing.
- What could go wrong
- This is a completed Phase 3 trial, but results are not yet published. The combination may not be significantly better than albendazole alone, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASCARIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Public Health Laboratory Ivo de Carneri
Chake Chake, Tanzania
More trials for these conditions
Other studies related to the condition(s) this trial covers.